DMO
Fluocinolone acetonide intravitreal implant for treating chronic DMO after inadequate response to prior therapy
Dec 30
2014
College statement on NICE guidance TA 301 – Fluocinolone acetonide intravitreal implant for treating chronic diabetic macular oedema after inadequate response to prior therapy (rapid review of technology appraisal guidance 271) December 2013